www.fdanews.com/articles/87255-endo-pharmaceuticals-july-option-implied-volatility-bid-up-into-6-22-06-pdufa
ENDO PHARMACEUTICALS JULY OPTION IMPLIED VOLATILITY BID UP INTO 6/22/06 PDUFA
June 1, 2006
Endo Pharmaceuticals researches, develops and markets both branded and generic pharmaceutical products for the treatment of pain and opioid analgesics. StreetInsider.com (http://www.streetinsider.com/news.php?id=917679&st=p)